Altay Therapeutics

Developer of therapeutics for chronic liver diseases and cancer

placeSan Francisco, California, United States calendar_todayFounded 2019 groups7 employees language altaytherapeutics.com

Innovation

4 patent families (1 granted) — focus: Chemistry & metallurgy; filing pace active. Cited 202 times.

YearFilings
20191
20241
20253

Social engagement

Social engagement: 1.7K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Y Combinator, Solve FSHD.

Investor typeCountShare
Venture capital360%
Other / undisclosed240%

Recent activity

20 Nov 2025
Milestone
regulatory
Coming soon